Literature DB >> 23624913

SCFs in the new millennium.

E K Lee1, J A Diehl1.   

Abstract

Substrate-specific degradation is a key feature of the ubiquitin proteasome system. Substrate specificity is typically directed by the E3 or ubiquitin ligase; such specificity can be conferred either by ligase modification or expression or conversely via modification of substrates that permit their recognition by a specific E3 ligase. The most well-known example of such complexes are the Cullin-RING ligases (CRLs). CRLs are composed of one of seven cullin-family scaffold proteins; the CRL serves as a scaffold that interacts directly with a RING-domain enzyme (Rbx1/2) through an extensive protein-protein interface within the globular C-terminal domain. At the N terminus, the cullin associates with an adaptor protein through cullin-repeat motifs. This adaptor, in turn, facilitates recruitment of a substrate-specifying factor that recruits the target to be ubiquitylated. The prototypical CRL is the cul1-containing complex, commonly referred to as the Skp1-Cul1-Fbox (SCF) ligase. SCF ligases contribute to the timely destruction of numerous substrates thereby ensuring normal cell growth. The importance of SCF function is highlighted by cancer-specific alterations in either the expression or the function of select F-box substrate-specific adaptors that results in neoplastic conversion. Herein, we discuss the current understanding of SCF function and contribution to cell biology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624913     DOI: 10.1038/onc.2013.144

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

1.  Orientia tsutsugamushi Ank9 is a multifunctional effector that utilizes a novel GRIP-like Golgi localization domain for Golgi-to-endoplasmic reticulum trafficking and interacts with host COPB2.

Authors:  Andrea R Beyer; Kyle G Rodino; Lauren VieBrock; Ryan S Green; Brittney K Tegels; Lee D Oliver; Richard T Marconi; Jason A Carlyon
Journal:  Cell Microbiol       Date:  2017-02-03       Impact factor: 3.715

Review 2.  The role of cullin proteins in gastric cancer.

Authors:  Peng Chen; Guo-Dong Yao
Journal:  Tumour Biol       Date:  2015-10-15

3.  Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8.

Authors:  Sungjin Ko; Jacquelyn O Russell; Jianmin Tian; Ce Gao; Makoto Kobayashi; Rilu Feng; Xiaodong Yuan; Chen Shao; Huiguo Ding; Minakshi Poddar; Sucha Singh; Joseph Locker; Hong-Lei Weng; Satdarshan P Monga; Donghun Shin
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

Review 4.  Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities.

Authors:  Ryan J Davis; Markus Welcker; Bruce E Clurman
Journal:  Cancer Cell       Date:  2014-10-13       Impact factor: 31.743

5.  FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition.

Authors:  J M Jeffery; M Kalimutho; P Johansson; D G Cardenas; R Kumar; K K Khanna
Journal:  Oncogene       Date:  2016-08-29       Impact factor: 9.867

6.  A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity.

Authors:  Jiye Liu; Tianyu Song; Wenrong Zhou; Lijie Xing; Su Wang; Matthew Ho; Zhengang Peng; Yu-Tzu Tai; Teru Hideshima; Kenneth C Anderson; Yong Cang
Journal:  Leukemia       Date:  2018-07-19       Impact factor: 11.528

Review 7.  Regulation of Mammalian DNA Replication via the Ubiquitin-Proteasome System.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 8.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

9.  The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding.

Authors:  James P Madigan; Feng Hou; Linlei Ye; Jicheng Hu; Aiping Dong; Wolfram Tempel; Marielle E Yohe; Paul A Randazzo; Lisa M Miller Jenkins; Michael M Gottesman; Yufeng Tong
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

10.  Mitogen-Activated Protein Kinase 14 Promotes AKI.

Authors:  Alberto Ortiz; Holger Husi; Laura Gonzalez-Lafuente; Lara Valiño-Rivas; Manuel Fresno; Ana Belen Sanz; William Mullen; Amaya Albalat; Sergio Mezzano; Tonia Vlahou; Harald Mischak; Maria Dolores Sanchez-Niño
Journal:  J Am Soc Nephrol       Date:  2016-09-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.